Please upgrade your browser.
Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis
Liver metastasectomy is an independent valuable tool in the treatment of metastatic RCC . . .
Consolidated practices and salaried doctors will leave fewer options for patients and longer waiting times for routine appointments.
IMBiotechnologies Receives FDA Clearance to Market Occlusin® 500 Biodegradable Microspheres in the U.S.
OCL 500 is a microspherical agent in development for the treatment of highly vascularised tumours, including hepatocellular carcinoma (HCC; liver cancer), renal cell carcinoma (RCC; kidney cancer) and uterine fibroids.
A CME activity from Clinical Care Options
The rate of unintentionally discovered renal masses has been increasing along with a parallel increased incidence of renal cell carcinoma both in men and women.
According to the Uwajima Tokushukai Hospital, the couple had asked the hospital in February whether it was possible to transplant the kidney from the wife, who had kidney cancer, to the husband.
Slides from the Fifth European International Kidney Cancer Symposium, held May 7 & 8, in London, England, are available online. Also online are selected presentations from the First European Kidney Cancer Nursing Conference.
Fuhrman Grade Provides Higher Prognostic Accuracy Than Nucleolar Grade for Papillary Renal Cell Carcinoma
Each grading system performs well but the predictive accuracy of Fuhrman grade is statistically superior to that of nucleolar grade and only.
Plans are continuing for the June 4 and 5 yard sale at Edgecomb Town Hall, to benefit the Kidney Cancer Association.
Mylan Inc. (MYL) has applied for U.S. regulatory approval to sell a generic version of Pfizer Inc.'s (PFE) Sutent cancer pill by challenging several patents on the drug.
|Powered by NeonCRM|